Role of CHEK2*1100delC in unselected series of non‐BRCA1/2 male breast cancers
- 21 October 2003
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 108 (3), 477-478
- https://doi.org/10.1002/ijc.11385
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- A CHEK2 Genetic Variant Contributing to a Substantial Fraction of Familial Breast CancerAmerican Journal of Human Genetics, 2002
- Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutationsNature Genetics, 2002
- BRCA1 and BRCA2 mutations in a population-based study of male breast cancerBreast Cancer Research, 2001
- hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage responseNature, 2000
- Founder BRCA1/2 Mutations among Male Patients with Breast Cancer in IsraelAmerican Journal of Human Genetics, 1999
- Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer FamiliesAmerican Journal of Human Genetics, 1998
- Germline BRCA2 mutations in men with breast cancerBritish Journal of Cancer, 1997
- Breast Cancer Risks in Relatives of Male Breast Cancer PatientsJNCI Journal of the National Cancer Institute, 1992
- Breast Cancer in Men: Aspects of Familial AggregationJNCI Journal of the National Cancer Institute, 1991